Market Performance Overview
The stock of Personalis Inc. (PSNL) declined by 0.25 % over the 24‑hour period that ended at 05:23 AM Central Europe on Saturday, 24 April 2026.
- Current trading price: USD 15.85
- Shares outstanding: 104.7 million
- Market capitalisation: USD 1.7 billion
- Volume traded in last 24 hours: USD 44.4 million
Since the close of the previous month, the share price has fallen 2.81 %.
- 200‑day simple moving average: USD 11.04
- 52‑week high: USD 18.89 (recorded on 21 August 2026)
- 52‑week low: USD 4.96 (recorded on 29 April 2026)
Comparative Performance of Related Stocks
| Ticker | 24‑hour change | Current price (USD) | Market cap (USD) | P/E ratio |
|---|---|---|---|---|
| TILE (Interface) | +4.11 % | 36.42 | 2 billion | 8.61 |
| TRN (Trinity Industries) | +2.34 % | 25.54 | 2 billion | 5.94 |
| EZPW (Ezcorp) | –11.6 % | 28.70 | 2 billion | 16.72 |
| LCII (Lci Industries) | +4.15 % | 84.87 | 2 billion | 9.67 |
| SAM (Boston Beer) | +7.65 % | 202.28 | 2 billion | – |
Company Profile
Personalis Inc. is a health‑care company headquartered in Menlo Park, United States. The firm focuses on genomic sequencing and analytics, providing services that support the development of personalized cancer vaccines and other next‑generation cancer immunotherapies. Personalis operates globally and is listed on the Nasdaq stock exchange. Additional information about the company’s products and initiatives can be found at www.personalis.com .
